Healthcare -
Biotechnology - NASDAQ - US
$ 7.83
0.643 %
$ 1.23 B
Market Cap
-6.07
P/E
OCUL - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities OCUL - Ocular Therapeutix, Inc.
170 M
LAST VALUE
671.80%
2 YEAR CAGR
19.86%
5 YEAR CAGR
38.20%
10 YEAR CAGR